VIVO Weill Cornell Medical College

Index
Log in

Search form

Home
People
Organizations
Research
Support

Bristol-Myers Squibb Company Funding Organization

Research

awards grant

Phase 2 study of Tovorafenib (Day 101) in Relapsed and Refractory Langerhans Cell Histiocytosis

©2025 VIVO Project | Terms of Use | Powered by VIVO

About
Contact Us
Support